Skip to content

The value of Artificial Intelligence assisted quantitative diagnosis of bone metastasis in Chinese population with prostate cancer

The value of Artificial Intelligence assisted quantitative diagnosis of bone metastasis in Chinese population with prostate cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101035
Enrollment
Unknown
Registered
2025-04-18
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer with bone metastasis

Interventions

Gold Standard:Whole body bone is used as qualitative diagnosis of bone metastasis. But there is no gold standard or reference standard for quantitative diagnosis of bone metastasis.
Index test:Artificial intelligence assisted quantitative diagnosis system for bone metastases

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Osteogenic bone metastases; 2.Single or multiple shots;

Exclusion criteria

Exclusion criteria: 1.Contains osteolytic bone metastases; 2.Negative bone scan; 3.Super Scan; 4.Patients with other malignant tumors;

Design outcomes

Primary

MeasureTime frame
sensitivity;Accuracy rate;Negative predictive value;Positive predictive value;

Secondary

MeasureTime frame
ROC curve;AUC;Odds ratio;

Countries

China

Contacts

Public ContactQianqian Geng

The First Affiliated Hospital of Xi'an Jiaotong University

gengqianq@126.com+86 29 8532 4286

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026